Abstract
Although the presentation of peptide–major histocompatibility complex class II (pMHC class II) complexes to CD4 T cells has been studied extensively in vitro, knowledge of this process in vivo is limited. Unlike the in vitro situation, antigen presentation in vivo takes place within a complex microenvironment in which the movements of antigens, antigen-presenting cells (APCs) and T cells are governed by anatomic constraints. Here we review developments in the areas of lymph node architecture, APC subsets and T cell activation that have shed light on how antigen presentation occurs in the lymph nodes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).
Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769–780 (2001).
Bonifaz, L. et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627–1638 (2002).
Askew, D., Gatewood, J., Olivas, E., Havenith, K. & Walker, W.S. A subset of splenic macrophages process and present native antigen to naive antigen-specific CD4+ T-cells from mice transgenic for an αβ T-cell receptor. Cell. Immunol. 166, 62–70 (1995).
Cassell, D.J. & Schwartz, R.H. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J. Exp. Med. 180, 1829–1840 (1994).
Jenkins, M.K. et al. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19, 23–45 (2001).
von Andrian, U.H. & Mackay, C.R. T-cell function and migration. N. Engl. J. Med. 343, 1020–1034 (2000).
Reinhardt, R.L., Khoruts, A., Merica, R., Zell, T. & Jenkins, M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410, 101–105 (2001).
Witmer, M.D. & Steinman, R.M. The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light-microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's patch. Am. J. Anat. 170, 465–481 (1984).
Witmer-Pack, M.D. et al. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse. J. Cell Sci. 104, 1021–1029 (1993).
Chang, M.D., Stanley, E.R., Khalili, H., Chisholm, O. & Pollard, J.W. Osteopetrotic (op/op) mice deficient in macrophages have the ability to mount a normal T-cell-dependent immune response. Cell. Immunol. 162, 146–152 (1995).
Zhong, G., Sousa, C.R. & Germain, R.N. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J. Exp. Med. 186, 673–682 (1997).
Lanzavecchia, A. Antigen-specific interaction between T and B cells. Nature 314, 537–539 (1985).
Itano, A.A. et al. Distinct dendritic cell populations sequentially present a subcutaneous antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19, 47–57 (2003).
Epstein, M.M., Rosa, F.D., Jankovic, D., Sher, A. & Matzinger, P. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182, 915–922 (1995).
Topham, D.J., Tripp, R.A., Hamilton-Easton, A.M., Sarawar, S.R. & Doherty, P.C. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. J. Immunol. 157, 2947–2952 (1996).
Townsend, S.E. & Goodnow, C.C. Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J. Exp. Med. 187, 1611–1621 (1998).
Valdez, Y. et al. Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8α+ dendritic cells in vivo. J. Exp. Med. 195, 683–694 (2002).
Garside, P. et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281, 96–99 (1998).
Fulcher, D.A. et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183, 2313–2328 (1996).
Steinman, R.M., Pack, M. & Inaba, K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156, 25–37 (1997).
MacPherson, G., Kushnir, N. & Wykes, M. Dendritic cells, B cells and the regulation of antibody synthesis. Immunol. Rev. 172, 325–334 (1999).
Gerosa, F. et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195, 327–333 (2002).
Ingulli, E., Mondino, A., Khoruts, A. & Jenkins, M.K. In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J. Exp. Med. 185, 2133–2141 (1997).
Byersdorfer, C.A. & Chaplin, D.D. Visualization of early APC/T cell interactions in the mouse lung following intranasal challenge. J. Immunol. 167, 6756–6764 (2001).
Miller, M.J., Wei, S.H., Parker, I. & Cahalan, M.D. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 296, 1869–1873 (2002).
Hommel, M. & Kyewski, B. Dynamic changes during the immune response in T cell-antigen-presenting cell clusters isolated from lymph nodes. J. Exp. Med. 197, 269–280 (2003).
Huleatt, J.W. & Lefrancois, L. Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J. Immunol. 154, 5684–5693 (1995).
del Hoyo, G.M. et al. Characterization of a common precursor population for dendritic cells. Nature 415, 1043–1047 (2002).
Ruedl, C., Koebel, P., Bachmann, M., Hess, M. & Karjalainen, K. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 165, 4910–4916 (2000).
Anjuere, F. et al. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 93, 590–598 (1999).
Shortman, K. & Liu, Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151–161 (2002).
Vremec, D. & Shortman, K. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159, 565–573 (1997).
Traver, D. et al. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 290, 2152–2154 (2000).
del Hoyo, G.M., Martin, P., Arias, C.F., Marin, A.R. & Ardavin, C. CD8α+ dendritic cells originate from the CD8α− dendritic cell subset by a maturation process involving CD8α, DEC-205, and CD24 up-regulation. Blood 99, 999–1004 (2002).
Naik, S., Vremec, D., Wu, L., O'Keeffe, M. & Shortman, K. CD8α+ mouse spleen dendritic cells do not originate from the CD8− dendritic cell subset. Blood 102, 601–604 (2003).
Nakano, H., Yanagita, M. & Gunn, M.D. CD11c+B220+GR-1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194, 1171–1178 (2001).
Ingulli, E., Ulman, D.R., Lucido, M.M. & Jenkins, M.K. In situ analysis reveals physical interactions between CD11b+ dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J. Immunol. 169, 2247–2252 (2002).
Julia, V. et al. A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 16, 271–283 (2002).
Yrlid, U. & Wick, M.J. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter. J. Immunol. 169, 108–116 (2002).
Pooley, J.L., Heath, W.R. & Shortman, K. Intravenous soluble antigen is presented to CD4 T cells by CD8− dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166, 5327–5330 (2001).
Iyoda, T. et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195, 1289–1302 (2002).
Manickasingham, S. & Reis e Sousa, C. Microbial and T cell-derived stimuli regulate antigen presentation by dendritic cells in vivo. J. Immunol. 165, 5027–5034 (2000).
Henri, S. et al. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167, 741–748 (2001).
Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144–1150 (2001).
Fonteneau, J.F. et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 101, 3520–3526 (2003).
Dalod, M. et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J. Exp. Med. 197, 885–898 (2003).
Krug, A. et al. Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J. Exp. Med. 197, 899–906 (2003).
Salomon, B., Cohen, J.L., Masurier, C. & Klatzmann, D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J. Immunol. 160, 708–717 (1998).
Kamath, A.T., Henri, S., Battye, F., Tough, D.F. & Shortman, K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100, 1734–1741 (2002).
Geissmann, F. et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196, 417–430 (2002).
Randolph, G.J., Inaba, K., Robbiani, D.F., Steinman, R.M. & Muller, W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11, 753–761 (1999).
Lappin, M.B., Kimber, I. & Norval, M. The role of dendritic cells in cutaneous immunity. Arch. Dermatol. Res. 288, 109–121 (1996).
Macatonia, S.E., Knight, S.C., Edwards, A.J., Griffiths, S. & Fryer, P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166, 1654–1667 (1987).
Romani, N. et al. Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance. Int. Rev. Cytol. 207, 237–270 (2001).
Nalefski, E.A. & Rao, A. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor. J. Immunol. 150, 3806–3816 (1993).
Wang, B., Amerio, P. & Sauder, D.N. Role of cytokines in epidermal Langerhans cell migration. J. Leukoc. Biol. 66, 33–39 (1999).
Cumberbatch, M. & Kimber, I. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 75, 257–263 (1992).
Stoitzner, P. et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 120, 266–274 (2003).
Peeler, J.S. & Niederkorn, J.Y. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J. Immunol. 136, 4362–4371 (1986).
Kumamoto, T. et al. Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat. Biotechnol. 20, 64–69 (2002).
Rudensky, A., Rath, S., Preston-Hurlburt, P., Murphy, D.B. & Janeway, C.A., Jr. On the complexity of self. Nature 353, 660–662 (1991).
Murphy, D.B. et al. Monoclonal antibody detection of a major self peptide. MHC class II complex. J. Immunol. 148, 3483–3491 (1992).
Inaba, K. et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163–2173 (1998).
Valladeau, J. et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71–81 (2000).
Vermaelen, K.Y., Carro-Muino, I., Lambrecht, B.N. & Pauwels, R.A. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193, 51–60 (2001).
Constant, S.L. et al. Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J. Clin. Invest. 110, 1441–1448 (2002).
Zhao, X. et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197, 153–162 (2003).
Randolph, G.J., Beaulieu, S., Lebecque, S., Steinman, R.M. & Muller, W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480–483 (1998).
Qu, C., Moran, T.M. & Randolph, G.J. Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC. J. Immunol. 170, 1010–1018 (2003).
Ebnet, K., Kaldjian, E.P., Anderson, A.O. & Shaw, S. Orchestrated information transfer underlying leukocyte endothelial interactions. Annu. Rev. Immunol. 14, 155–177 (1996).
Picker, L.J. & Siegelman, M.H. in Fundamental Immunology (ed. Paul, W.E.) 145–197 (Raven, New York, 1993).
Kaldjian, E.P., Gretz, J.E., Anderson, A.O., Shi, Y. & Shaw, S. Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. Int. Immunol. 13, 1243–1253 (2001).
Gretz, J.E., Norbury, C.C., Anderson, A.O., Proudfoot, A.E. & Shaw, S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192, 1425–1440 (2000).
Okada, S., Albrecht, R.M., Aharinejad, S. & Schraufnagel, D.E. Structural aspects of the lymphocyte traffic in rat submandibular lymph node. Microsc. Microanal. 8, 116–133 (2002).
Ruedl, C., Koebel, P. & Karjalainen, K. In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts. J. Immunol. 166, 7178–1782 (2001).
Turley, S.J. et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288, 522–527 (2000).
Finkelman, F.D., Lees, A., Birnbaum, R., Gause, W.C. & Morris, S.C. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157, 1406–1414 (1996).
Lu, Q. & Lemke, G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293, 306–311 (2001).
Scott, R.S. et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411, 207–211 (2001).
Savill, J. & Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784–788 (2000).
Fadok, V.A. et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85–90 (2000).
Fadok, V.A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101, 890–898 (1998).
Ding, L., Linsley, P.S., Huang, L.Y., Germain, R.N. & Shevach, E.M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151, 1224–1234 (1993).
Inaba, K. et al. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186, 665–672 (1997).
Zhong, G., Reis e Sousa, C. & Germain, R.N. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. USA 94, 13856–13861 (1997).
Dadaglio, G., Nelson, C.A., Deck, M.B., Petzold, S.J. & Unanue, E.R. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6, 727–738 (1997).
Porgador, A., Yewdell, J.W., Deng, Y., Bennink, J.R. & Germain, R.N. Localization, quantitation, and in situ detection of specific peptide- MHC class I complexes using a monoclonal antibody. Immunity 6, 715–726 (1997).
Acknowledgements
We thank T. Leonard for help with the animation. Supported by grants from the National Institutes of Health and the Irvington Institute of Immunological Research.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Itano, A., Jenkins, M. Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol 4, 733–739 (2003). https://doi.org/10.1038/ni957
Issue Date:
DOI: https://doi.org/10.1038/ni957
This article is cited by
-
Constructing and Validating a Network of Potential Olfactory Sheathing Cell Transplants Regulating Spinal Cord Injury Progression
Molecular Neurobiology (2023)
-
Amoeba-inspired magnetic microgel assembly assisted by engineered dextran-binding protein for vaccination against life-threatening systemic infection
Nano Research (2023)
-
Coexistence of HLA and KIR ligand mismatches as a risk factor for viral infection early after cord blood transplantation
Bone Marrow Transplantation (2022)
-
Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
Journal of Nanobiotechnology (2021)
-
Armamentarium of Cryoprotectants in Peptide Vaccines: Mechanistic Insight, Challenges, Opportunities and Future Prospects
International Journal of Peptide Research and Therapeutics (2021)